Mercator MedicalFRA:MM2 +0.18%60 Gross Margin % is 35.13% as of Mar. 2026, which is 46% above its 10-year median of 24.12. GuruFocus rates FRA:MM2 with a GF Score™ of 60/100 and a GF Value™ of €11.48 (Fairly Valued). The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Mercator Medical ranks worse than 80.87% on this metric.
Mercator Medical SA gross margin has been in long-term decline. The average rate of decline per year is -14.3%.
The historical rank and industry rank for Mercator Medical's Gross Margin % or its related term are showing as below:
FRA:MM2'
s Gross Margin % Range Over the Past 10 Years
Min: 16.28 Med: 24.12 Max: 64.87
Current: 30.27
During the past 13 years, the highestGross Margin % of Mercator Medical was 64.87%. The lowest was 16.28%. And the median was 24.12%.
FRA:MM2's Gross Margin % is ranked worse than 80.87% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs FRA:MM2: 30.27
Mercator Medical had a gross margin of 35.13% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Mercator Medical was -14.30% per year.
Mercator Medical (FRA:MM2) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Mercator Medical had a gross margin of 35.13% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Mercator Medical Gross Margin % Related Terms
Mercator Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Mercator Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MM2 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Mercator Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Mercator Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Mercator Medical (FRA:MM2) has a Gross Margin % of 35.13% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Mercator Medical and its competitors. This is 46% above median its historical median of 24.12. Over the past decade, Mercator Medical's Gross Margin % has ranged from 16.28 to 64.87. According to the industry distribution chart, Mercator Medical ranks #651 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 80.9%.
Is Mercator Medical's Gross Margin % too high?
Mercator Medical's current Gross Margin % of 35.13% is 46% above median its 10-year median of 24.12. Over the past 10 years, this metric has ranged from a low of 16.28 to a high of 64.87. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Mercator Medical's value of 35.13% is 32.5% below this industry median. Based on the distribution chart, Mercator Medical ranks #651 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Mercator Medical has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #651 out of 805 companies for Gross Margin %. This places Mercator Medical in the lower half of its industry. The industry median Gross Margin % is 52.07. Mercator Medical's value of 35.13% is 32.5% below this benchmark. Historically, Mercator Medical's own Gross Margin % has ranged from 16.28 to 64.87 over the past decade. While the company's 10-year median is 24.12 vs. the industry median of 52.07, Mercator Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current Gross Margin % of 35.13% is 32.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current Gross Margin % is 35.13%, which is 46% above median its own 10-year median of 24.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.48, compared to a current price of €11.20 — trading 2.4% below its estimated fair value. The current Gross Margin % is 35.13%, which is 46% above median its 10-year median of 24.12 and 32.5% below the Medical Devices & Instruments industry median of 52.07. Mercator Medical's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Gross Margin % is 35.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (FRA:MM2) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued.
The current stock price of €11.20 is trading 2.4% below its estimated GF Value™ of €11.48.
GuruFocus considers Mercator Medical to be Fairly Valued.
Key valuation signals for FRA:MM2:
Gross Margin %: 35.13% (46% above median its 10-year median of 24.12)
GF Value™: €11.48 vs. price of €11.20 (2.4% below fair value)
Industry Position: 32.5% below the Medical Devices & Instruments median (#651 of 805)
No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
60GF Score
Get the complete analysis for FRA:MM2
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM2 has been successfully added to your 
